Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2020 Jan 11;2020:9210261. doi: 10.1155/2020/9210261

Prevalence of Hyperhomocysteinaemia and Associated Factors among Ethiopian Adult Population in a 2015 National Survey

Feyissa Challa 1,, Tigist Getahun 1, Meron Sileshi 1, Bikila Nigassie 1, Zeleke Geto 1, Genet Ashibire 1, Terefe Gelibo 2, Solomon Teferra 3, Daniel Seifu 4, Yohannes Sitotaw 5, Abebe Bekele 6, Ebba Abate 1, Kaleab Baye 7
PMCID: PMC7201487  PMID: 32420383

Abstract

Hyperhomocysteinaemia (HHcy) is an independent risk factor for major cardiovascular diseases, but data on the prevalence and predictors of HHcy in low- and middle-income countries like Ethiopia are scant. The aim of this study was to estimate the prevalence of HHcy and associated risk factors in the Ethiopian adult population. A cross-sectional survey on risks of noncommunicable diseases (NCDs) using the STEPwise approach to surveillance (STEPS) survey was conducted between April and June 2015. A total of 4,175 study participants were surveyed. Serum homocysteine (Hcy) and metabolic profile were determined using Cobas Integra 400 Plus and CardioChek PA analyzer, respectively. Factors associated with HHcy were determined using logistic regression. The mean serum tHcy concentration was 14.6 μmol/L, with 16.4 μmol/L in males and 13.4 μmol/L in females. Overall, 38% had HHcy, with figures in males (49%) higher than females (30%). Increased age, being male, and high blood pressure and/or taking blood pressure medication, as well as low consumption of fruit and/or vegetables, were independent risk factors for HHcy. In conclusion, the prevalence of HHcy among the adult Ethiopian population is alarmingly high. Improving diets through the promotion of fruit and vegetable consumption is needed to reduce the risk of NCDs.

1. Introduction

Homocysteine (Hcy), 2-methyl-4-mercapto butyric acid, is a sulfur-containing amino acid required for normal biosynthesis of the amino acids methionine and cysteine [1]. Under normal conditions, serum Hcy concentration is strictly maintained by a complex pathway (remethylation or transsulfuration) which involves different factors such as folic acid, vitamin B12 (cobalamin), vitamin B6 (pyridoxine), methylenetetrahydrofolate reductase enzyme (MTHFR), methionine synthase, and cystathionine beta-synthase [2, 3]. However, folate and B-vitamin deficiencies [4], lifestyle behaviors (e.g., smoking, physical inactivity, and chronic alcohol consumption) [5], and genetic defects (i.e., polymorphisms in MTHFR) [6] are all associated with hyperhomocysteinaemia (HHcy) (Hcy ≥ 15 μmol/L) [7].

HHcy is an independent risk factor for many chronic diseases including cardiovascular-related diseases such as [8] atherosclerosis [9], hypertension [10], stroke and coronary artery diseases [11, 12], and type 2 diabetes [13]. HHcy is also associated with increased risk of neural tube defects [14] and adverse pregnancy outcomes [15]. Every 5 μmol/L increase in Hcy was found to be associated with increased risk of cerebrovascular (59%) and coronary heart diseases (32%) [9].

While Ethiopia has made a remarkable progress in reducing the burden of infectious disease, there is mounting evidence that chronic diseases including cardiovascular diseases (CVDs) and diabetes are on the rise [16]. HHcy could be associated with this rise in the burden on NCDs, but little is known about its prevalence and associated factors. This is unfortunate because such data could help prioritize and inform interventions that aim to reduce the burden of chronic diseases in Ethiopia. Therefore, our study aimed at evaluating the prevalence of HHcy and its associated risk factors in a nationally representative of sample of the Ethiopian adult population. To our knowledge, this is the first nationally representative study that evaluated the prevalence of HHcy and its predictors.

2. Methods

2.1. Study Design

A nation-wide cross-sectional survey on risk factors for NCDs was conducted (April-June 2015) using the World Health Organization (WHO) STEPwise approach to surveillance (STEPS version 3.1) [17]. The data were collected using the following three steps: Step 1: interview-based assessment of demographic and behavioural characteristics of the study population, Step 2: physical measurements to determine proportion of the study population with raised blood pressure, overweight, and obesity, and Step 3: biochemical measurements to determine the proportion of the study population with diabetes, raised blood glucose, and abnormal lipid profile. In addition to core and expanded modules, some optional modules (khat use) were included in each of the three steps. A total of 35 experienced and well-trained survey teams, each comprising three survey members (1 supervisor and 2 data collectors), were involved in the data collection.

2.2. Sampling

A total of 4,175 study participants were included in the national NCD survey. Representative samples of all regions of the country, including Addis Ababa and Dire Dawa city administrations, were collected using the sampling frame of the Ethiopian population and housing census [18]. Study participants meeting the following eligibility criteria were included in the study: 15–69 years of age; permanent residents (>6 months residence) of the survey; and providing consent. Individuals in military camps, dormitories, nursing homes, and refugee camps and pregnant women were excluded from the study. Eligible adults aged 15–69 years in each household were selected using the Kish method [19]. Only one eligible participant per household was selected.

2.3. Ethical Approval

Ethical clearance was obtained from the Ethical Review Committees of the Ethiopian Public Health Institute (EPHI) and the National Research and Ethics Review Committee (NERC). Informed consent was obtained from each study participant or from parents/guardians for children less than 18 years of age. The objectives of the study were explained to the participants by the data collectors. The study was conducted according to the principles expressed in the Declaration of Helsinki. Participants with abnormal physical or laboratory findings were counseled and referred to the nearest health facility for further follow-up and medical care.

3. Data Collection

3.1. Demographic and Lifestyle Factors

Demographic and socioeconomic status, tobacco use, alcohol consumption, fruit and vegetable consumption, physical activity, khat use, and history of raised blood pressure or medication for blood pressure, was assessed.

Physical activity levels were assessed and categorized as high, moderate, and low. High-level physical activity was defined as vigorous-intensity activity at least three days per week achieving at least 1500 metabolic equivalent time (MET) minutes per week, or seven or more days of any combination of walking and moderate- or vigorous-intensity activities achieving at least 3000 MET minutes per week.

Moderate level physical activity was defined as three or more days of vigorous-intensity activity of at least 20 minutes per day; or five or more days of moderate-intensity activity or walking for at least 30 minutes per day; or five or more days of any combination of walking and moderate- or vigorous-intensity activities achieving at least 600 MET minutes per week.

A person not meeting any of the abovementioned criteria was considered to have a low physical activity level [20].

3.2. Fruit and Vegetable Consumption

Fruit and vegetable consumption of study participants was captured by asking about the number of days and servings of fruits and vegetables consumed in a typical week. The following serving sizes were considered: for raw green leafy vegetables, 1 serving = one cup; for cooked or chopped vegetables, 1 serving = ½ cup; for fruit (apple, banana, orange, etc.), 1 serving = 1 medium size piece; for chopped, cooked, and canned fruit, 1 serving = ½ cup; and for juice from fruit, 1 serving = ½ cup. Servings were measured by showing pictorial show cards.

3.3. Physical Measurements

Height and weight were measured using an equipment that uses infrared and ultrasonic technologies (Deluxe model number GBS-721). The instrument measures body weight and height and calculates body mass index (BMI; kg/m2).

Blood pressure measurements were taken three times (in three minutes interval) from the right arm of a sitting participant using a Boso-Medicus Uno instrument (Boso, Germany). The participants were allowed to rest for 15 minutes before measurements were taken. The maximum deviation of cuff pressure measurement was ±3 mmHg, and the three measurements were averaged.

3.4. Biochemical Measurements

Both capillary and venous blood samples were obtained after an overnight fast (8–10 h). Capillary blood glucose, total cholesterol, and high-density lipoprotein (HDL) analyses were performed in the field using CardioChek PA Analyzer (Polymer Technology System Inc., Indianapolis, IN). For tHcy analysis, 3–5 ml of whole blood was collected and immediately centrifuged at 3500 rpm to separate serum. Serum samples were transported and stored at −80°C at EPHI-Clinical Chemistry Laboratory until further analyses. Serum tHcy and triglycerides were analyzed using Cobas Integra 400® Plus (Roche Diagnostics GmbH, Mannheim, Germany) at the Clinical Chemistry Laboratory of EPHI [21, 22].

3.5. Data Management

Descriptive statistics were calculated for all of the variables. Continuous variables were reported as mean and standard deviation (SD). Categorical variables were reported as frequencies and percentages. Differences in subgroups were analyzed using chi-square. Logistic regression was run to identify risk factors associated with HHcy, after adjusting for covariates gender, age, BMI, residence, marital status, occupational status, level of education, income, physical activity, fruit and/or vegetable consumption, blood glucose, total cholesterol, triglycerides, smoking status, alcohol drinking status, and raised blood pressure or taking blood pressure medication. Hcy values were categorized as normal (Hcy value <15 μmol/L) and HHcy (Hcy value ≥ 15 μmol/L). Odds ratio (OR) and corresponding 95% confidence intervals (CIs) are presented. The data were analyzed using the SPSS software version 22.00 (SPSS Inc. Chicago, IL, USA), and mean differences with p values <0.05 were considered statistically significant.

4. Results

About 60% of the study participants were females and 39% were 15–29 years of age (Table 1). About half (53%) of the study participants had no formal education. More than two-thirds of the study participants had a high level of physical activity, about 5% were smokers, and >90% consumed alcohol (Table 2). Only 1% met the WHO criteria for adequate fruit and vegetable consumption. About a third of the participants were either undernourished (24%; BMI < 18.5) or overweight/obese (8%; BMI > 25.0). Among study participants, 3% had raised blood sugar, and 17% had high blood pressure or were on blood pressure medication, 24% had high serum triglyceride level, and greater than 60% of the participants had a low HDL level.

Table 1.

Sociodemographic characteristics of the study participants, Ethiopia, 2015.

Variables n (%) Total Male Female
4175 (100) 1722 (41.2) 2453 (58.8)
Age (years)
 15–29 1625 (38.9) 626 (36.4) 999 (40.7)
 30–44 1526 (36.6) 621 (36.1) 905 (36.9)
 45–59 739 (17.7) 337 (19.6) 402 (16.4)
 60–69 285 (6.8) 138 (8.0) 147 (6.0)

Residence
 Urban 952 (22.8) 283 (16.4) 669 (27.3)
 Rural 3223 (77.2) 1439 (83.6) 1784 (72.7)

BMI (kg/m2)
 Low (≤18.5) 956 (23.9) 452 (26.4) 504 (22.0)
 Normal (19–24) 2703 (67.5) 1161 (67.9) 1542 (67.2)
 High (≥25) 348 (8.7) 98 (5.7) 250 (10.9)

Geographic region
 Tigray 682 (16.3) 257 (14.9) 425 (17.3)
 Afar 167 (4.0) 63 (3.7) 104 (167)
 Amhara 794 (19.0) 343 (19.9) 451 (18.4)
 Oromiya 961 (23.0) 392 (22.8) 569 (23.2)
 Somali 276 (6.6) 105 (6.1) 171 (7.0)
 B. Gumuz 214 (5.1) 104 (6.0) 110 (4.5)
 SNNPR 527 (12.6) 232 (13.5) 295 (12.0)
 Gambela 239 (5.7) 131 (7.6) 108 (4.4)
 Harari 59 (1.4) 22 (1.3) 37 (1.5)
 Dire Dawa 51 (1.2) 30 (1.7) 21 (0.9)
 Addis Ababa 205 (4.9) 43 (2.5) 162 (6.6)

Marital status
 Single 1326 (31.8) 466 (27.1) 860 (35.1)
 Married or cohabiting 2848 (68.2) 1256 (72.9) 1592 (64.9)

Occupational status
 Employed 379 (9.2) 216 (12.8) 163 (6.7)
 Skilled worker 2336 (56.7) 1248 (74.2) 1088 (44.6)
 Housewife 959 (23.3) 8 (0.5) 951 (39.0)
 Unemployed 446 (10.8) 211 (12.5) 235 (446)

Level of education
 No formal education 2227 (53.3) 712 (41.3) 1515 (61.8)
 Primary education 1472 (35.3) 762 (44.3) 710 (28.9)
 Secondary education 259 (6.2) 113 (6.6) 146 (6.0)
 College and above 217 (5.2) 135 (7.8) 82 (3.3)

Income (x 1000 birr)
 <12 2335 (68.1) 922 (63.3) 1413 (71.6)
 12–18 422 (12.3) 200 (13.7) 222 (11.2)
 18–23 206 (6.0) 115 (7.9) 91 (4.6)
 23–30 213 (6.2) 96 (6.6) 117 (5.9)
 >30 254 (7.4) 123 (8.4) 131 (6.6)

BMI, = body mass index; low BMI ≤ 18.5 kg/m2; normal BMI = 18.5–24.99 kg/m2; high BMI ≥ 25 kg/m2.

Table 2.

Lifestyle factors and biochemical measures of study participants, Ethiopia, 2015.

Variables n (%) Total Male Female p value
4175 (100) 1722 (41.2) 2453 (58.8)
Physical activity level
 Low 609 (14.7) 159 (9.3) 450 (18.5) <0.001
 Moderate 679 (16.4) 178 (10.4) 501 (20.6)
 High 2850 (68.9) 1372 (80.3) 1478 (60.8)

Current smoking
 Yes 233 (5.6) 202 (11.7) 31 (1.3) <0.001
 No 3942 (94.4) 1520 (88.3) 2422 (98.7)

Current alcohol intake
 Yes 1708 (92.8) 833 (95.3) 875 (90.6) <0.001
 No 132 (7.2) 41 (4.7) 91 (9.4)

Fruit and vegetable consumption
 Yes 50 (1.2) 18 (1.0) 32 (1.3) 0.448
 No 4125 (98.8) 1704 (99.0) 2421 (98.7)

Blood sugar level
 Normal (<110 mg/dl) 3740 (92.5) 1546 (92.4) 2194 (92.5) 0.140
 Impaired fasting glucose (110–125 mg/dl) 185 (4.6) 69 (4.1) 116 (4.9)
 Raised blood sugar (≥126 mg/dl) 119 (2.9) 58 (3.5) 61 (2.6)

Raised blood pressure/on blood pressure medicationΔ
 Yes 722 (17.3) 280 (16.3) 442 (18.0) 0.139
 No 3453 (82.7) 1442 (83.7) 2011 (82.0)

Total cholesterol level (mg/dl)
 <200 3796 (92.6) 1621 (95.3) 2175 (90.7) <0.001
 ≥200 304 (7.4) 80 (4.7) 224 (9.3)

Triglyceride level (mg/dl)
 <150 3192 (76.5) 1319 (76.6) 1873 (76.4) 0.856
 ≥150 983 (23.5) 403 (23.4) 580 (23.6)

HDL level Φ
 Normal 1400 (34.7) 673 (40.5) 1400 (30.7) <0.001
 Low 2630 (65.3) 990 (59.5) 2630 (69.3)

Homocysteine (μmol/L)b 14.6 ± 6.8 16.4 ± 7.5 13.4 ± 6.0 <0.001

Homocysteine level (μmol/L)
 <15 2593 (62.1) 879 (51.0) 1714 (69.9) <0.001
 ≥15 1582 (37.9) 843 (49.0) 739 (30.1)

ΔSBP = systolic blood pressure; DBP = diastolic blood pressure; raised blood pressure (SBP ≥ 140 and/or DBP ≥ 90 mmHg). ΦHDL level: low HDL level for males, <40 mg/dl, and for females, <50 mg/dl. bValues are mean ± standard deviation.

The mean serum tHcy concentration was 14.6 μmol/L, with 16.4 μmol/L in males and 13.4 μmol/L in females. Overall 38% had HHcy, 49% in males and 30% in females (p > 0.05). The prevalence of HHcy increased with age, in both men and women (Table 2). 15–29 years of age had the lowest prevalence of HHcy and 60–69 years of age had the highest prevalence of HHcy (Figure 1).

Figure 1.

Figure 1

Mean serum level of homocysteine by age, gender, and residence, Ethiopia, 2015.

The results of the logistic regression analyses for HHcy are presented in Table 3. All factors with a p value <0.05 in the bivariate analysis were entered into the multivariable model that controlled for confounding factors. In bivariate analysis, we did not find any association between HHcy and BMI (p=0.508), marital status (p=0.203), total cholesterol level (p=0.234), triglyceride level (p=0.065), and current alcohol intake (p=0.093). Logistic regression analysis for HHcy using age group, gender, regions, occupational status, level of education, quartiles of income, fruit and/or vegetable consumption, blood glucose level, HDL, smoking status, and raised blood pressure or taking medication as covariates was performed.

Table 3.

Factors associated with hyperhomocysteinaemia in the Ethiopian adult population, 2015.

Variables n (%) Homocysteine concentration (Hcy) Adjusted OR (95% CI) p value
<15 μmol/L ≥15 μmol/L
Sex
 Female 1714 (69.9) 739 (30.1) 1 <0.001
 Male 879 (51.0) 843 (49.0) 2.16 (1.79, 2.62)

Age (years)
 15–29 1107 (68.1) 518 (31.9) 1
 30–44 934 (61.2) 592 (38.8) 1.31 (1.08, 1.58) 0.007
 45–59 412 (55.8) 327 (44.2) 1.80 (1.41, 2.30) <0.001
 60–69 140 (49.1) 145 (50.9) 2.06 (1.47, 2.90) <0.001

Geographic region
 Addis Ababa 109 (53.2) 96 (46.8) 1
 Tigray 467 (68.5) 215 (31.5) 0.50 (0.33, 0.76) 0.001
 Afar 85 (50.9) 82 (49.1) 1.23 (0.74, 2.03) 0.433
 Amhara 595 (74.9) 199 (25.1) 0.34 (0.22, 0.51) <0.001
 Oromia 639 (66.5) 322 (33.5) 0.53 (0.36, 0.79) 0.002
 Somali 84 (30.4) 192 (69.6) 3.19 (1.90, 5.34) <0.001
 B. Gumuz 103 (48.1) 111 (51.9) 1.02 (0.62, 1.67) 0.954
 SNNPR 359 (68.1) 168 (31.9) 0.49 (0.32, 0.74) 0.001
 Gambela 105 (43.9) 134 (56.1) 1.47 (0.82, 2.62) 0.194
 Harari 33 (55.9) 26 (44.1) 1.31 (0.56, 3.07) 0.536
 Dire Dawa 14 (275) 37 (72.5) 3.37 (1.46, 7.78) 0.005

Occupational status
 Unemployed 281 (63.0) 165 (37.0) 1
 Employed 209 (55.1) 170 (44.9) 1.17 (0.76, 1.82) 0.470
 Skilled worker 1437 (61.5) 899 (38.5) 1.11 (0.77, 1.59) 0.583
 Housewife/homemaker 646 (67.4) 313 (32.6) 1.04 (0.69, 1.55) 0.863

Level of education
 No formal education 1365 (52.6) 862 (54.5) 1
 Primary education 960 (37.0) 512 (32.4) 0.96 (0.79, 1.17) 0.697
 Secondary education 157 (6.1) 102 (6.4) 1.18 (0.82, 1.70) 0.379
 College and above 111 (4.3) 106 (6.7) 1.52 (0.98, 2.37) 0.063

Income quartiles (×1000 birr)
 <12 1491 (69.6) 844 (65.6) 1
 12–18 257 (12.0) 165 (12.8) 1.17 (0.85, 1.62) 0.337
 18–23.3 110 (5.1) 96 (7.5) 1.09 (0.75, 1.59) 0.643
 23.3–30 128 (6.0) 85 (6.6) 1.22 (0.79, 1.89) 0.380
 >30 157 (7.3) 97 (7.5) 1.16 (0.76, 1.78) 0.493

Physical activity level
 Low 385 (15.0) 224 (14.3) 1
 Moderate 454 (17.6) 225 (14.4) 1.02 (0.77, 1.36) 0.889
 High 1734 (67.4) 1116 (71.3) 1.30 (1.02, 1.66) 0.034

Fruit and vegetable consumption
 Yes 46 (1.8) 4 (0.3) 1
 No 2547 (98.2) 1578 (99.7) 9.57 (2.83, 32.30) <0.001

Blood sugar level (mg/dl)
 Normal (<110) 2364 (63.2) 1376 (36.8) 1
 Impaired fasting glucose (110–125) 95 (51.4) 90 (48.6) 1.26 (0.73, 2.16) 0.413
 Raised blood sugar (≥126) 71 (59.7) 48 (40.3) 1.44 (0.76, 2.74) 0.266

High-density lipoprotein level (HDL)Φ
 Normal 824 (58.9) 576 (41.1) 1
 Low 1691 (64.3) 939 (35.7) 1.09 (0.93, 1.29) 0.291

Currently smoking
 No 2487 (63.1) 1455 (36.9) 1
 Yes 106 (45.5) 127 (54.5) 0.84 (0.58, 1.20) 0.336

Raised blood pressure/on blood pressure medication Δ
 No 2193 (63.5) 1260 (36.5) 1
 Yes 400 (55.4) 322 (44.6) 1.55 (1.27, 1.91) <0.001

ΦHDL level: low HDL level for males, <40 mg/dl, and for females, <50 mg/dl. ΔSBP = systolic blood pressure; DBP = diastolic blood pressure; raised blood pressure (SBP ≥ 140 and/or DBP ≥ 90 mmHg).

Being male (AOR = 2.16; 95% CI, 1.79–2.62), increased age (AOR = 3.19; 95% CI, 1.90, 5.34), residing in Somali or Dire Dawa region (AOR = 3.37; 95% CI, 1.46–7.78), raised blood pressure (AOR = 1.55; 1.27–1.91), and low fruit and vegetable consumption relative to WHO recommendations (AOR = 9.57; 2.83, 32.30) were independent predictors of increased HHcy.

5. Discussion

The present study has identified that the prevalence of HHcy is alarmingly high. Age, male gender, low fruit and vegetable consumption, and high blood pressure or taking blood pressure medication were the major risk factors. There was also high regional variability in the prevalence of HHcy, with an increased risk of HHcy in some regions (e.g., Dire Dawa and Somali).

The high prevalence of HHcy in the Ethiopian population is concerning and could in part explain the increased mortality and morbidity from NCDs in Ethiopia. Indeed, Misganaw et al. [16] have recently shown that ischemic heart disease, ischemic stroke, and diabetes are ranked 1st, 6th, and 8th in the cause of age-standardized death for Ethiopia. While several lifestyle factors such as physical inactivity and smoking are often found to be associated with HHcy [23], these were not significant predictors of HHcy in this Ethiopian sample. This could be due to the high to medium level of physical activity observed in most of our study participants and the relatively low level of smoking.

The current study showed that HHcy was higher in males, which is consistent with previous studies [24, 25]. The gender difference in HHcy is likely to be associated with sex-related hormones, the higher phosphocreatine synthesis in males, and the higher rate of remethylation and transmethylation in females than in males [26]. In this study, similar to previous findings [25, 27], the prevalence of HHcy increased with age. This might be due to reduced bioavailability of folate with age [28].

Low consumption of fruits and vegetables and high blood pressure were major predictors of HHcy. Indeed, many studies have documented the advantage of increased fruit and vegetable consumption in promoting health and preventing NCDs including cardiovascular diseases [29]. There could be several explanations for this: First, dark green leafy vegetables are particularly good sources of folate, and adequate folate status could decrease the risk of HHcy. The low level of fruit and vegetable consumption is in line with the findings of the National Food Consumption Survey and is further supported by the relatively high prevalence of folate deficiency in Ethiopia [30, 31].

Second, fruits and vegetables are good sources of antioxidants and polyphenols that can help lower total serum Hcy, prevent lipid oxidation in arterial vessel walls, lower blood pressure, and improve endothelial function. This is supported by a recent study that used a quantile regression approach to show the inverse relationship between fruit and vegetable consumption and serum Hcy [32].

The high regional variability in the prevalence of HHcy could thus partly be attributed to variability in regional dietary patterns, but this would warrant further studies. For instance, Somali and Dire Dawa had the highest HHcy prevalence. These regions also have one of the lowest consumption of fruits and vegetables [30, 33]. Different studies indicated that Hcy is considered as a risk factor for hypertension even though the causal relationship between hypertension and Hcy is limited. HHcy is often accompanied by increased reactive oxygen species, matrix metalloproteinase, and decreased endothelial nitric oxide which all causes stiffness and vascular constriction that can lead to hypertension [34]. In this study, raised blood pressure or taking blood pressure medication was associated with HHcy.

The present study had several strengths, including the nationally representative sampling, large sample size, investigation of lifestyle factors, anthropometry, and several biomarkers associated with HHcy. However, certain limitations need to be considered when interpreting our findings. First, the present study is cross-sectional, and hence, causal inferences cannot be made. Second, even though MTHFR 677CT polymorphism and intake of folate and vitamin B12 can all affect serum tHcy concentrations, they were not assessed in the present study; however, fruit and vegetable consumption was assessed to reflect dietary patterns.

6. Conclusions

Despite the abovementioned limitations, the present study is the first nationally representative study that determined the prevalence of HHcy and its associated factors. The study highlighted the alarmingly high prevalence of HHcy, but also showed that increased age, being male, increased blood pressure or taking blood pressure medication, and low fruit and vegetable consumption were key predictors of HHcy. Improving diets through the promotion of fruits and vegetable consumption could be an effective strategy to prevent the adverse effects (i.e., CVD) associated with HHcy.

Acknowledgments

Funding and technical support was provided by the WHO-Regional Office and the Ministry of Health in Ethiopia. We also like to extend our gratitude to the staff of the Clinical Chemistry Laboratory. Special thanks are due to the Health System and Reproduce Research Directorate of the EPHI that coordinated the survey.

Data Availability

The datasets can be made available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors' Contributions

F. C. and A. B. designed the study; F. C., T. G., M. S., B. N., Z. G., and G. A. analyzed and interpreted the data; T. G., S. T., D. S., Y. S., E. A., K. B., and F. C. wrote the article. All authors have read and reviewed this manuscript.

References

  • 1.Kennedy D. B vitamins and the brain: mechanisms, dose and efficacy—a review. Nutrients. 2016;8(2) doi: 10.3390/nu8020068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schalinske K. L., Smazal A. L. Homocysteine imbalance: a pathological metabolic marker. Advances in Nutrition. 2012;3(6):755–762. doi: 10.3945/an.112.002758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Currò M., Gugliandolo A., Gangemi C., Risitano R., Ientile R., Caccamo D. Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells. Neurochemical Research. 2014;39(8):1485–1495. doi: 10.1007/s11064-014-1338-7. [DOI] [PubMed] [Google Scholar]
  • 4.Kluijtmans L. A. J., Young I. S., Boreham C. A., et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood. 2003;101(7):2483–2488. doi: 10.1182/blood.v101.7.2483. [DOI] [PubMed] [Google Scholar]
  • 5.Ganji V., Kafai M. R. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. The American Journal of Clinical Nutrition. 2003;77(4):826–833. doi: 10.1093/ajcn/77.4.826. [DOI] [PubMed] [Google Scholar]
  • 6.Frosst P., Blom H. J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics. 1995;10(1):111–113. doi: 10.1038/ng0595-111. [DOI] [PubMed] [Google Scholar]
  • 7.Guo H., Chi J., Xing Y., Wang P. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina. Indian Journal of Medical Research. 2009;129(3):279–284. [PubMed] [Google Scholar]
  • 8.Waśkiewicz A., Sygnowska E., Broda G. Homocysteine concentration and the risk of death in the adult Polish population. Kardiologia Polska. 2012;70(9):897–902. [PubMed] [Google Scholar]
  • 9.Wald D. S. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325(7374):1202–1206. doi: 10.1136/bmj.325.7374.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lu H., Lu Z. H., Li P. G., Wang Y. Y., Yan Z. Y. Elevated homocysteine and hypertension in xinjiiang province, China. Ethnicity and Disease. 2010;20:7–10. [PubMed] [Google Scholar]
  • 11.Sacco R. L., Anand K., Lee H.-S., et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the northern manhattan study. Stroke. 2004;35(10):2263–2269. doi: 10.1161/01.str.0000142374.33919.92. [DOI] [PubMed] [Google Scholar]
  • 12.Folsom A. R., Nieto F. J., McGovern P. G., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B Vitamins : the atherosclerosis risk in communities (ARIC) Study. Circulation. 1998;98(3):204–210. doi: 10.1161/01.cir.98.3.204. [DOI] [PubMed] [Google Scholar]
  • 13.Huang T., Ren J. J., Huang J., Li D. Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach. BMC Genomics. 2013;14(1):p. 867. doi: 10.1186/1471-2164-14-867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Peker E., Demir N., Tuncer O., et al. The levels of vitamın B12, folate and homocysteine in mothers and their babies with neural tube defects. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29:2944–2948. doi: 10.3109/14767058.2015.1109620. [DOI] [PubMed] [Google Scholar]
  • 15.Bergen N., Jaddoe V., Timmermans S., et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the generation R study. BJOG: An International Journal of Obstetrics & Gynaecology. 2012;119(6):739–751. doi: 10.1111/j.1471-0528.2012.03321.x. [DOI] [PubMed] [Google Scholar]
  • 16.Misganaw A., Haregu T. N., Deribe K., et al. National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990–2015: findings from the Global Burden of disease study 2015. Population Health Metrics. 2017;15(1) doi: 10.1186/s12963-017-0145-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.WHO. STEP Wise Approach to Surveillance (STEPS) Geneva, Switzerland: WHO; 2009. http://www.who.int/chp/steps/en/ [Google Scholar]
  • 18.Central statistical Agency of Ethiopia. Population and Housing Census 2007 Report. Addis Ababa, Ethiopia: Central Statistical Agency; 2007. [Google Scholar]
  • 19.Kish L. Survey Sampling. New York, NY, USA: John Wiley & Sons Inc.; 1995. [Google Scholar]
  • 20.WHO. Global Recommendations on Physical Activity For Health. Vol. 60. Geneva, Switzerland: World Health Organization; 2010. [PubMed] [Google Scholar]
  • 21.Roche Diagnostics Corporation. Homocystine Enzymatic Assay. Method Sheet: 2015 Version 3. Indianapolis, IN, USA: Roche Diagnostics Corporation; 2015. [Google Scholar]
  • 22.Roche Diagnostics Corporation. Triglycerides. Method Sheet: 2014 Version 2 Indianapolis. Indianapolis, IN, USA: Roche Diagnostics Corporation; 2014. [Google Scholar]
  • 23.Bree A. D., Verschuren W. M., Blom H. J., Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. American Journal of Epidemiology. 2001;154(2):150–154. doi: 10.1093/aje/154.2.150. [DOI] [PubMed] [Google Scholar]
  • 24.Refsum H., Nurk E., Smith A. D., et al. The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. The Journal of Nutrition. 2006;136(6):1731S–1740S. doi: 10.1093/jn/136.6.1731s. [DOI] [PubMed] [Google Scholar]
  • 25.Wang Y., Li X., Qin X., et al. Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45–75 years. British Journal of Nutrition. 2013;109(7):1284–1293. doi: 10.1017/s0007114512003157. [DOI] [PubMed] [Google Scholar]
  • 26.Fukagawa N. K., Martin J. M., Wurthmann A., Prue A. H., Ebenstein D., O’Rourke B. Sex-related differences in methionine metabolism and plasma homocysteine concentrations. The American Journal of Clinical Nutrition. 2000;72(1):22–29. doi: 10.1093/ajcn/72.1.22. [DOI] [PubMed] [Google Scholar]
  • 27.Guo S., Pang H., Guo H., et al. Ethnic differences in the prevalence of high homocysteine levels among low-income rural Kazakh and Uyghur adults in far western China and its implications for preventive public health. International Journal of Environmental Research and Public Health. 2015;12(5):5373–5385. doi: 10.3390/ijerph120505373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.O’Leary F., Flood V. M., Petocz P., Allman-Farinelli M., Samman S. B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients. The Journal of Nutrition, Health & Aging. 2011;15(6):485–489. doi: 10.1007/s12603-010-0330-4. [DOI] [PubMed] [Google Scholar]
  • 29.Schuit A. J., van Loon A. J. M., Tijhuis M., Ocké M. C. Clustering of lifestyle risk factors in a general adult population. Preventive Medicine. 2002;35(3):219–224. doi: 10.1006/pmed.2002.1064. [DOI] [PubMed] [Google Scholar]
  • 30.EPHI. Ethiopia National Food Consumption Survey. Addis Ababa, Ethiopia: EPHI; 2013. [Google Scholar]
  • 31.Haidar J., Melaku U., Pobocik R. S. Folate deficiency in women of reproductive age in nine administrative regions of Ethiopia: an emerging public health problem. South African Journal of Clinical Nutrition. 2010;23(3):132–137. doi: 10.1080/16070658.2010.11734327. [DOI] [Google Scholar]
  • 32.Melaku E. J., Steluti J., Fisberg R. M., Marchioni D. M. L. A quantile regression approach can reveal the effect of fruit and vegetable consumption on plasma homocysteine levels. PLoS One. 2014;9(11) doi: 10.1371/journal.pone.0111619.e111619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.EPHI. Ethiopian National Nutrient Survey Report. Addis Ababa, Ethiopia: EPHI; 2016. [Google Scholar]
  • 34.Ganguly P., Alam S. F. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 2015;14(1):p. 6. doi: 10.1186/1475-2891-14-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets can be made available from the corresponding author upon reasonable request.


Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES